Php220 - Old Drugs Turned New for Ultra Orphan Disease: A Challenge for Payers or for the Industry?

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1114
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

New Drugs for Mental Diseases?: New Diseases for Old Drugs?

Journal of the Royal Society of Medicine
Medicine
1987English

New Drugs for Old Targets

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Psy60 - Orphan Versus Ultra-Orphan Drugs Prices in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Breathing New Life Into an Old Target: Pulmonary Disease Drugs for Parkinson’s Disease Therapy

Genome Medicine
Molecular MedicineGeneticsMolecular Biology
2017English

Registering New Drugs for Low-Income Countries: The African Challenge

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2011English

Psy130 - The Relationship Between Disease Type and Conditional or Exceptional Approval by Ema for Orphan Drugs in 2017

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Old Drugs as New Treatments for Neurodegenerative Diseases

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2018English

A Template for New Drugs Against Alzheimer’s Disease

Cell
BiochemistryGeneticsMolecular Biology
2013English

New Therapies, Old Problems, Or, a Plea for Neuromodesty

AJOB Neuroscience
Neuroscience
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy